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Abstract
Urine may be a waste product, but it contains an enormous amount of information. Well-standardized procedures for collection, transport, sample 
preparation and analysis should become the basis of an effective diagnostic strategy for urinalysis. As reproducibility of urinalysis has been greatly 
improved due to recent technological progress, preanalytical requirements of urinalysis have gained importance and have become stricter. Since the 
patients themselves often sample urine specimens, urinalysis is very susceptible to preanalytical issues. Various sampling methods and inappro-
priate specimen transport can cause important preanalytical errors. The use of preservatives may be helpful for particular analytes. Unfortunately, 
a universal preservative that allows a complete urinalysis does not (yet) exist. The preanalytical aspects are also of major importance for newer 
applications (e.g. metabolomics). The present review deals with the current preanalytical problems and requirements for the most common urinary 
analytes.
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Introduction
Urinalysis is the third major diagnostic screening 
test in the clinical laboratory, only preceded by se-
rum/plasma chemistry profiles and complete 
blood count analysis (1,2). For decades, microscop-
ic urine sediment analysis has been the gold stand-
ard (3). The introduction of new technologies and 
automation has improved the accuracy and pro-
ductivity of the process (4). On the other hand, 
consolidation of laboratories has increased the 
physical distance between patient and laboratory, 
which creates a major preanalytical challenge. It is 
mandatory to focus on the preanalytical phase in 
order to improve the reliability of test results (5) 
and to lower the costs of health care (6). In the clin-
ical laboratory, total quality could be defined as 
the guarantee of a correctly performed activity 
throughout the total testing process, providing 
valuable medical diagnosis and efficient patient 
care. Improvements in both reliability and stand-
ardization of analytical techniques, reagents and 
instrumentation have contributed to a remarkable 
10-fold reduction in the analytical error rate over 
the last 30 years. Furthermore, also progress in in-
formation technology and quality assurance meth-
ods have contributed to a further reduction of di-
agnostic errors. Nevertheless, the lion share of er-
rors in laboratory diagnostics (and in urinalysis in 
particular) falls outside the analytical phase; both 
preanalytical and postanalytical steps are much 
more vulnerable (7).
Various subphases have been identified in the pre-
analytical phase of urinalysis. Need for the test, 
collection and transport of the sample to the labo-
ratory, receipt of the specimen by the laboratory 
and sample preparation and transport to the prop-
er laboratory section for testing (8) can be impor-
tant potential sources of error. As more effort 
needs to be spent in the preanalytical phase for 
the further reduction of errors (9), in the present 
paper we give an overview of the preanalytical 
challenges of urinalysis.
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Patient preparation and sampling 
procedures
The laboratory is responsible for correct informa-
tion regarding optimal patient preparation and 
best sampling procedure. Interpretation of test re-
sults is only possible when these conditions are 
fulfilled. Informing the patient goes far beyond 
only explaining the practical aspects of urine sam-
pling. More specifically, the effect of possible bio-
logical confounders such as dietary intake, diure-
sis, exercise and other interferents, should be em-
phasized. If necessary, illustrated instructions for 
sampling can be provided (10). Despite the exist-
ing guidelines, the importance of a proper preana-
lytical procedure for collecting urine specimens is 
usually not known by the patients. In a recent pa-
per, Miler et al. showed that a 24-hour urine sam-
ple was not properly collected in more than half of 
the informed outpatients, which were often older 
(mostly > 65 years) and suffering from a chronic 
disease. The prescribed instructions were not fol-
lowed, some volume of the urine sample was dis-
carded or an improper container was used. To de-
crease the number of errors in the preanalytical 
phase, laboratory staff, general practitioners and 
patients should be educated and an active pro-
moting of the preanalytical procedures by the lab-
oratory staff should be encouraged. In case of an 
incorrect sample procedure, the urine collection 
should be repeated (11).
The quality of the reported results could also be 
influenced by variables in specimen processing. 
Sample preparation is more essential for different 
particle analysis techniques in comparison with 
urine test strip analysis and microbiological cul-
ture. As an example of the importance of interfer-
ents, the influence of commercially available baby 
soaps on tetrahydrocannabinol (THC) immu-
noassays can be mentioned. Beyond healthcare, 
newborn drug screening plays also an important 
role in the legal domain. Mixtures of drug-free 
urine with various products that commonly con-
tact newborns were tested using immunoassays. 
Addition of variable commercially available baby 
soaps to drug-free urine resulted in a measurable 
response in THC immunoassays. Due to the pres-
ence of surfactants with the THC assay, soap and 
wash products used for newborn and infant care 
can potentially cause false positive screening test 
results, leading to involvement by social services 
or false child abuse allegations (12).
Which precautions should be implemented?
Minimizing contamination can already be achieved 
by implementation of simple precautive measures. 
A 20% reduction of the number of false positive 
urine cultures can be achieved by washing the 
glans penis of men or the introitus of women 
(10,13,14). Due to the influence on the viability of 
bacteria, the use of soap or antiseptics is not rec-
ommended (10,15).
Which sampling procedure to choose for 
urinalysis?
A large amount of sampling procedures is availa-
ble with specific advantages and disadvantages. 
When deciding the best procedure, one should 
take into consideration the patient’s characteris-
tics (suspected microorganisms or presence of a 
urinary catheter). Sample quality can only be war-
ranted if standardized instructions for urine collec-
tion are available (10,13). Clean-catch urine or mid-
stream portions of first morning urine samples col-
lected in a sterile urine container are the most 
commonly obtained specimens in routine prac-
tice. However, overnight bacterial growth in the 
bladder is likely, which can affect casts and cells. 
Morphological studies showed a higher reproduc-
ibility when incubation time was ± 1-2 h. There-
fore, using second morning urine specimens is 
sometimes recommended (urine samples voided 
2-4 h after the first morning urine) (16). In a recent 
multicenter study (17), results obtained from first-
voided and mid-stream urine samples were com-
pared. In healthy subjects, two consecutive sam-
ples of the first morning micturition were collected 
by a vacuum system, the first from the first-void 
and the second from the mid-stream. Routine uri-
nalysis was performed using dip-stick automated 
analyzers and automated particle analyzers. 
Counts of epithelial cells, erythrocytes and leuko-
cytes, but not for casts were significantly higher in 
the first-voided samples. A significantly higher 
count of epithelial cells, erythrocytes and leuko-
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cytes was also observed between females and 
males in first-voided samples, whereas no signifi-
cant difference could be found in mid-stream sam-
ples. Overall prevalence of subjects with cellular 
elements count exceeding upper reference limits 
was also higher in first-voided than in mid-stream 
samples. Mid-stream urine was confirmed as the 
most appropriate sample, since the presence of 
contaminating elements, such as bacteria, analytes 
and formed particles are minimized (10).
The European Confederation of Laboratory Medi-
cine (ECLM) has proposed a classification of refer-
ence measurement procedures for urine measure-
ments. Different levels of accuracy have been de-
fined (level 1-4). Level 1 represents rapid or screen-
ing methods, amenable to point-of-care testing, 
often with an ordinal scale result. Some may be 
suitable as screening methods for larger laborato-
ries if specificity, sensitivity, or both are high 
enough. Level 2 has been defined as methods suit-
able for routine laboratories; many of them will be 
automated or could be automated in the future. 
Level 3 represents the ‘‘State of the art’’ methods 
whose performance is satisfactory enough for pur-
poses of comparison. Finally, level 4 stands for best 
methods (primary reference measurement proce-
dures = reference and definitive methods). Based 
on those guidelines, erythrocytes and leukocytes 
can be examined by strip examination (level 1), 
standardized urine sediment (level 2) or advanced 
chamber counting (level 3); albumin and other 
proteins can detected by strip examination (level 
1), quantitative field measurement (level 2) or ac-
curate measurement traced to the CRM 470 pro-
tein standard (level 3); bacterial analysis should be 
performed by dipslide culture (level 1), culture with 
a 1 µL disposable loop for 24-48 h (level 2) or quan-
titative titration of 10-100 µL inocula on two differ-
ent [cysteine lactose electrolyte deficient medium 
(CLED) and haematin] agar plates (level 3) and 
urine volume rate (diuresis) could be analysed by 
strip examination (level 1), creatinine and refrac-
tometry (level 2) or quantitative measurement of 
osmolality (level 3) (18).
Which sampling container is preferable?
Collection of urine specimens is a major source of 
preanalytical variability. A sterile collection is man-
datory for bacteriological culture of urine samples. 
Urine collection container design should enable 
easy sampling, ensuring an optimal transport and 
allowing sensitive detection of pathogens. Fur-
thermore, they should be free of interfering agents 
and made of non-absorbing materials, with no in-
fluence on any analyte. The collection volume 
should be determinant factor for the size of the 
urine container. Additional requirements may be 
needed in function of diagnostic procedures (e.g. 
light sensitive analytes as porphyrins and uro-
bilinogen require amber-colored urine containers) 
(8,10). The original primary sample should be di-
vided into different smaller aliquots for morpho-
logical, microbiological and chemical analyses to 
decrease the risk of contamination. Easy filling from 
primary containers without risk of spillage should 
be one of the characteristic of secondary contain-
ers. These transparent tubes preferably have a 
round bottom, which allow a better resuspension 
of the sediment following centrifugation (10).
For reducing the risk of errors and contamination, 
commercially available vacuum systems have been 
developed, allowing direct sample aspiration into 
a secondary container. Vacuum systems can only 
be used for chemical analysis and are not recom-
mended for particle analysis. During vacuum aspi-
ration, the pressure difference results in a desinte-
gration of brittle casts. Vacuum aspiration is re-
sponsible for a significant reduction of hyaline and 
cellular cast counts (respectively at least 58% and 
51%) in comparison with conventional test tubes 
(4). The reduction of cast counts depends on the 
vacuum during aspiration (19). A destruction of 
cellular casts (which are only weakly hold together 
by the sticky Tamm-Horsfall protein) is observed 
due to mechanical damage during vacuum aspira-
tion, with a release of their cellular inclusions, as 
demonstrated by an increased amount of erythro-
cytes and leukocytes. Erythrocyte counts in urine 
specimens were higher (> 25% increase) in vacu-
um tubes than in conventional tubes (4). At this 
moment, only particle analysis will result in true 
identification of casts. The available assays meas-
uring Tamm-Horsfall protein can provide informa-
tion on the presence of casts, without verifying the 
nature of the casts. The influence of vacuum sys-
tems on other elements is limited. No difference in 
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flowcytometric erythrocyte count and the per-
centage of nonlysed erythrocytes has been ob-
served for urine samples with normal osmolality 
(conductivity) in conventional and vacuum test 
tubes. However, the erythrocyte count and the 
percentage of nonlysed erythrocytes in vacuum 
tubes were lower than in conventional urine tubes 
(minimum 20% and 31% reduction) in samples 
with low conductivity. Peroxidase-based haemo-
globin dipstick reactions were comparable. Be-
cause of the growing importance of (micro)albu-
minuria in the diagnosis of kidney disease, more 
attention has been paid to the particular preana-
lytical aspects of this analyte. At low albumin con-
centrations, adsorption to the surface of urine con-
tainers can lead to marked relative losses (20). 
Nonspecific adsorption of urinary albumin was cal-
culated at < 1 mg/L with hydrophilic surfaces and 
< 2 mg/L with nonhydrophilic surfaces. Binding to 
surfaces may also result in protein denaturation. 
Addition of nonionic detergents or using hy-
drophilic surfaces may reduce both adsorption 
and denaturation. Albumin is relatively stable at 
the air-liquid interface when rapid mixing gener-
ates foaming. Frozen storage at temperatures 
above -80 °C (particularly at -20 °C) produces vari-
ous modifications to the albumin molecule (21).
Transport and preservation
Is it a matter of time?
An increased time lag between sampling and anal-
ysis, a lack of temperature control and a lack of ad-
dition of a preservative to samples for which uri-
nalysis cannot be performed within two hours of 
collection, will lower the quality of urinary test re-
sults. Table 1A and 1B give an overview of the sta-
bility of different particles and test strip parame-
ters (22). The exact sampling time and delays ex-
ceeding the specified limits should be document-
ed. Point-of-care analyses are not subject to this 
delay, but may as well be affected by various ana-
lytical issues.
Use of preservatives: why, which and when?
Alkaline pH, low relative density and low osmolali-
ty can induce a rapid lysis of some urine particles 
after collection (22). Addition of stabilizers usually 
prevents metabolic changes of urine analytes and 
overgrowth of bacteria. In a recent study, the value 
of transport tubes containing a preservative for 
maintenance of the semiquantitative and qualita-
tive assessment of urine cultures was again dem-
onstrated, especially in cases when the sample 
transport time > 2 h (23). However, preservatives 
may affect some chemical properties and alter the 
appearance of particles. An appropriate label car-
rying a hazard symbol should give information 
dealing with any preservative (10,13,22). Risk of 
sample dilution and its potential influence on out-
come of urine culture are important issues when 
using liquid mixtures.
The correct preservative to specimen ratio should 
be respected when samples are preserved for 
transport and analysis (8). The recommended 
specimen volume is mostly indicated on the con-
tainer with a marking line. If too much sample is 
added to the container, the concentration of the 
Table 1a. Influence of temperature on stability of particle analysis (adapted from reference 21).
Particle -20 °C 4-8 °C 20-25 °C
Red blood cell NA 1-4 h 1 h - 24 h (> 300 mOsmol/kg)
White blood cell NA 1-4 h 1 h (pH > 7.5) - 24 h (pH < 6.5)
Acanthocytes NA 2 days 1 day (> 300 mOsmol/kg)
Casts Not allowed NA 2 days
Bacteria NA 24 h 1-2 h
Epithelial cells NA NA 3 h
NA - data not available.
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preservative gets too low, reducing the preserva-
tive action. In the inverse situation, an excessive 
amount of preservative may inhibit bacterial 
growth. The minimal urine volume needed in or-
der to obtain correct results has been determined 
for two different preservative-containing systems 
(24). Traditionally, ethanol (50%) is selected to pre-
serve cellular particles, although only a partly pre-
vented lysis of red and white blood cells is ob-
served. Addition of polyethylene glycol (20 g/L) to 
the ethanol fixative (Saccomanno’s fixative) im-
proves preservation quality (10,25). Lyophilised 
formulations should be chosen among the com-
mercial preservatives as there is no risk of sample 
dilution of spillage. Also, containers supplemented 
with boric acid alone or in combination with for-
mic acid or other stabilizing media, are used 
(10,26). Table 2A depicts the effect of commonly 
used preservatives on flow cytometric particle 
analysis. In contrast to casts, epithelial cells and 
leukocytes, the stabilization of erythrocytes is ex-
tremely difficult, probably due to cellular shrink-
age following the addition of formaldehyde solu-
tions (25).
In function of the required testing, a difference in 
preservative demands is requested. In particular, 
laboratories should focus on the analytical test 
quality, as more reliable results ask for stricter pre-
analytical demands. Several specific proteins are 
instable in urine, which could be resolved by inhi-
bition of their degradation by the addition of some 
preservatives. Although the 24-hour urine collec-
tion is the reference method for quantification of 
stable chemical analytes, contamination, incorrect 
collection and incorrect calculation of urinary vol-
ume can cause preanalytic errors. The albumin: 
creatinine ratio (or protein:creatinine ratio) on a 
random urine sample, which is not influenced by 
variation in water intake and rate of diuresis, is a 
recommended alternative (27). Correlation be-
tween protein:creatinine ratio and 24-hour protein 
excretion may not be accurate for proteinuria lev-
els > 1 g/L. For monitoring proteinuria, the reliabil-
ity of protein:creatinine ratio still needs to be prov-
en (9,22).
When analysis of the test strip can be performed 
within 24 hours and the urine specimen has been 
refrigerated, no preservatives are needed (10). 
Freezing cannot be regarded as an alternative for 
refrigeration in preserving samples for urine test 
strip analysis. The selection of the preservative 
partly depends on the required analyses since 
some enzymatic reactions may be influenced by 
preservatives (Table 2B) (10,26,28). The use of boric 
acid affects a number of test strip reactions. This 
limits the proposed combination of test strip anal-
ysis and urine culture to obtain an optimal diag-
nostic test use. Boric acid keeps urinary pH below 
7, prevents dissolution of pus cells (29) and is asso-
Analyte 4-8 °C 20-25 °C
Red blood cells 1-3 h 4-8 h
White blood cells 1 day 1 day
Proteins NA > 2 h (unstable at pH > 7.5)
Glucose 2 h < 2 h
Nitrites 8 h 4 days
NA - data not available.
Table 1b. Influence of temperature on test strip analysis (adapt-
ed from reference 21).
Particle Borate + Formiate + Sorbitol 10 mL/L Formaline 0 .15 mol/L NaCl 80 mL/L Ethanol + 20 g/L PEG
Red blood cells
White blood cells
Casts
Epithelial cells
Bacteria
Table 2a. Influence of preservatives on particle analysis by flow cytometry.
Legend:  Very good  Good  Not good
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ciated with false negative strip test results (e.g. 
protein, white blood cells and ketones). A multi-
center study showed a successful preservation of 
most test strip results as long as 6-24 h (nitrite and 
glucose were the exceptions) using the preserva-
tive-containing BD Plus C&S plastic, BD Plus UAP 
(BD Diagnostics-Preanalytical Systems, Franklin 
Lakes, NJ, USA) and Greiner Stabilur tubes (Greiner 
Bio-One, Kremsmünster, Austria) (28). Although it 
cannot be considered as good laboratory practice, 
in some laboratories dip slides are put in a urine 
containing test tube while using the same sample 
for other types of analyses. Several reports high-
light contamination of the sample by glycine (2), 
iodine (30), caffeine (31) and other constituents of 
the test strip, which leads to unnecessary further 
investigation. To resolve this problem, urine should 
be transferred to the strip instead of immersing 
the test strip into the specimen. Dipping is only ac-
ceptable if a separate aliquot is available.
A detailed table for the correct preservation of 24-
hour urine specimens published by the National 
Committee for Clinical Laboratory Standards (NC-
CLS) and CLIS is based on the recommendations of 
the major textbooks and the largest reference clin-
ical laboratories (e.g. Mayo Medical Laboratories). 
As specimen requirements can be conflicting 
when a number of tests are required, several dif-
ferent approaches have been proposed ranging 
from collection of multiple 24-hour specimens to 
the use of containers with a two-way split or three-
way split of the preservative. When a 24-hour urine 
volume exceeds the volume of a single container, 
the urine of two 24-hour containers should be well 
mixed before analysis. It is recommended to regu-
larly check the current requirement from reference 
laboratories as they may change from time to time 
(10,13,32,33).
Interfering effect of different urine 
components on test strip analyses
Due to the presence of alkaline medication or stale 
urine, highly buffered alkaline urine (pH 9) may re-
sult in false-positive test strip results for proteinu-
ria. A similar phenomenon is observed (a) if the 
test strip is left submerged in the urine sample for 
a too long time period, (b) if quaternary ammoni-
um compounds are used for cleaning the urine 
containers, (c) if patients are treated with polyvi-
nylpyrrolodione or phenazopyridine, (d) if skin 
cleansers with chlorhexidine gluconate are used 
or (e) if blood, vaginal discharge, pus, semen or 
heavy mucus are contaminating the specimen. 
False-negative results are reported in diluted urine 
or in the presence of slightly elevated proteinuria 
other than albuminuria (globulin, immunoglobu-
lin, light chains) (10,34).
At this moment, no urinary components have 
been associated with false-positive glucose oxi-
dase reactions. However, contamination with 
strong oxidizing cleaning agents peroxide or hy-
drochloric acid can result in a false-positive reac-
tion. Using automated methods for some brands 
of reagent strips, falsely elevated urinary glucose 
test strip results can also be caused by elevated 
urobilinogen concentrations (34). In addition, the 
temperature can affect the sensitivity of glucose 
due to its effect on the enzyme reaction. An alka-
line pH, a urinary tract infection, an elevated spe-
Analyte Boric acid Formaldehyde Hg salts Chloral hexidine
Red blood cells
White blood cells
Proteins
Glucose
pH
Bacteria
Table 2b. Influence of preservatives on test strip reactions.
Legend:  Stabilisation  Limited stabilisation  No stabilisation
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cific gravity and high urinary ascorbate concentra-
tions [oral or parenteral intake of large doses of 
ascorbic acid or vitamin C (2-15 g/day)] may de-
crease the sensitivity of glucose oxidase (10,35). 
For that reason the test should be repeated at least 
one day after the last intake of vitamin C. Using 
some reagent strips, false-negative results have 
been reported in the presence of moderately high 
ketone concentrations (40 mg/dL) (36).
False-positive reactions for ketones or ketone bod-
ies are seen in (a) urine samples with a low pH and 
a high specific gravity, in (b) urine containing a 
high amount of levodopa metabolites, (c) in the 
presence of compounds with sulfhydryl groups 
(e.g. captopril) or in (d) highly pigmented urine 
samples (34). An improper storage can lead to 
false-negative results and beta-hydroxybutyrate is 
not detected (10,34).
Screening tests for occult blood can become false-
positive by (a) certain oxidizing contaminants (hy-
pochlorites when cleaning urine containers or in 
the presence of bacterial peroxidases by a high 
bacterial content) (37,38) or by (b) contamination 
with povidone-iodine (39), (c) menstrual blood, (d) 
semen or (e) myoglobinuria (34,40). As urine dip-
sticks are characterized by a very high sensitivity 
for intact erythrocytes and free hemoglobin, tran-
sient hematuria is a common finding. To rule out 
transient hematuria, the urinalysis should be re-
peated on different occasions in asymptomatic pa-
tients with a positive dipstick result for hematuria 
and an otherwise normal urinalysis. If persistently 
positive results for blood are found, clinicians 
should confirm the presence of erythrocytes in 
urine by a microscopic sediment analysis. A strong-
ly positive dipstick in combination with a non-cor-
responding negative urine sediment can be ex-
plained by lysis of erythrocytes and release of free 
hemoglobin in patients with dilute urine of normal 
colour. The same finding in subjects with grossly 
bloody urine specimens is suggestive of intravas-
cular hemolysis or rhabdomyolysis (40). A com-
ment released together with observed (un-
changed) dipstick test results pointing to the prob-
able interference could be informative. In contrast, 
false-negative results can be found when the ex-
amination is delayed, when urine specimens are 
not well mixed before testing or when using for-
malin as preservative. A lower sensitivity is some-
times seen after the intake of a high amount of 
ascorbic acid, after the intake of captopril, in urine 
samples with a high concentration of proteins or 
nitrites or with a high specific gravity (10,34).
The interpretation of the bilirubin pad is unreliable 
after the expire date. False-positive reactions can 
be induced by indican and metabolites of etodol-
ac, by the intake of phenazopyridine or large doses 
of chlorpromazine or phenazopyridine. A lower 
sensitivity is observed after the intake of large 
amounts of ascorbic acid, in the presence of a high 
nitrite concentration or after the exposure to light 
(10,34).
Atypical reactions with the urobilinogen pad have 
been reported by several interferering compo-
nents: p-aminobenzocic acid, sulphonamides, p-
aminosalicyclic acid, phenazopyridine and p-
dimethylaminobenzaldehyde. In addition, col-
oured urine and prophobilinogen can result in 
false-positive reactions. False-negative results can 
be seen in improperly stored samples (exposure to 
light) or in the presence of formaldehyde (2 g/L) or 
in urine containing nitrite (34).
False-positive results for nitrite are seen after a too 
long standing at room temperature for several 
hours or when urine appears red. Urine samples 
with a high concentration of ascorbic acid, with a 
high specific gravity, with a low pH (≤ 6) or with an 
abnormally high urobilinogen concentration will 
reduce the test sensitivity (34).
The leukocyte esterase test can give false-positive 
reactions due to the use of strong oxidizing agents, 
formaldehyde (0.4 g/L) or sodium azide. In addi-
tion, coloured urine (bilirubinuria and beet inges-
tion) can result in a positive reaction. Contamina-
tion of urine with vaginal discharge/mucus or the 
intake of some drugs (nitrofurantion, clavulanic 
acid, meropenem and imipenem) can lead to mis-
interpretation. Vitamin C intake, proteinuria (> 5 
g/L), glucosuria (> 20 g/L), 1% boric acid, trypsin in-
hibitor, oxalate or mercuric salts may decrease the 
sensitivity of the test (10,34,41).
The limitations of the detection of bacteria by mul-
tiple test strips are the following: coloured urine 
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and in vitro growth can result in false-positive re-
actions, whereas a short bladder incubation time, 
Gram-positive bacteria, vitamin C or no intake of 
vegetables can give false-negative results (10).
The relative density/specific gravity can become 
falsely high in case of proteinuria (> 1 g/L) or the 
presence of ketoacids. Alkaline urine, glucose and 
urea can decrease the sensitivity of the analysis 
(10).
Finally, formaldehyde is known to lower the pH; 
hemoglobin, myoglobin (> 50 mg/L) and ethylen-
ediaminetetraacetic acid (EDTA) have an influence 
on the creatinine determination and the determi-
nation of ascorbic acid can become false-positive 
by similar reducing agents (10).
Particle analysis
European urinalysis guidelines (10) have proposed 
to examine particles < 1 hour after voiding at am-
bient temperature or < 4 hours if refrigerated to 
avoid material lysis. Refrigeration causes a precipi-
tation of phosphates and urates, which may affect 
analysis of these analytes. Hence, preparing a sep-
arate non-refrigerated aliquot is necessary if differ-
entiation of urinary crystals is requested. Assess-
ment of leukocytes gets doubtful when the analy-
sis is performed more than 4 hours after sampling. 
However, without adding a preservative, leukocyte 
preservation can be fairly good even when sam-
ples were stored at room temperature for 72 h. 
These positive results in preserving leukocytes 
should be interpreted with caution, as only sam-
ples of adults had been selected (28). In pediatric 
specimens kept at room temperature, a rapid de-
crease in the white blood cell count was observed 
(42). Particle lysis accelerates with increasing pH 
(too long time lag between collection and analy-
sis, Proteus sp. infections) (10,25,43,44) and lower 
relative density (typically seen in young children).
Falsely elevated red blood cell counts measured 
by flow cytometry could be the result of undis-
solved powder in the urine container (test tube) 
causing a background noise signal (28). Morpho-
logical erythrocyte analysis remains a separate 
component of urine particle analysis. Urinary tract 
and renal diseases can be associated with haema-
turia. However, also a general bleeding disorder or 
physiological reasons (e.g. strenuous physical ex-
ercise) and vaginal contamination (e.g. menstrua-
tion), could be the underlying explanation of this 
phenomenon. The morphology of urinary eryth-
rocytes may reflect the origin of bleeding: dysmor-
phic erythrocytes (red cells characterized by an 
abnormal shape or size), especially acanthocytes 
or G1 cells (a ring-shaped body with one or more 
protruding blebs), point toward renal disease. Red 
blood cells with a normal morphology usually 
originate from the lower urinary tract (16). A more 
general use of this time-consuming test is ham-
pered by the lack of unequivocal criteria for identi-
fication and quantitation of dysmorphic erythro-
cytes and the special training (phase contrast mi-
croscopy) needed for this examination (45). Morn-
ing urine specimens should be preferred as correct 
evaluation of erythrocyte morphology depends 
on osmolality and pH (46). An alternative approach 
to differentiate the bleeding site is based on spe-
cific protein analysis, e.g. urinary IgG:albumin and 
alpha-2-macroglobulin: albumin ratios (47).
Manual methods
Several methods have been developed for the de-
tection of urinary elements. In the classical manual 
particle analysis, the presence of formed elements 
like red and white blood cells, epithelial cells (sq-
uamous and non-squamous epithelial cells), uri-
nary casts (hyaline and cellular), spermatozoa, bac-
teria, yeasts, various artefacts (e.g. pollen, starch, 
glass hair, paper, textile), mucus, lipids and crystals 
(e.g. oxalate, carbonate, phosphate, urate and cys-
tine) is checked microscopically (4,10,48,49). In 
spite of standardization, intra-assay coefficients of 
variation of routine sediment analysis can become 
as high as 100%, when residual volume of the sed-
iment and centrifugation efficiency are taken into 
account (4,6,48,50). Hence, a sediment method 
can never be considered as reference of quantita-
tive urinary particle counting (10).
Although centrifugation with removal of superna-
tant is necessary for sample concentration, it re-
mains a major source of errors. Counting of native 
urine avoids the errors created by centrifugation; 
this procedure lowers the analytical sensitivity. In 
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comparison with bacterial cultures, the analytical 
sensitivity for bacteria is poor at lower counts. The 
performance figure of bacteriuria depends on the 
operator’s skill, the bacterial species (bacilli or coc-
ci), and on the interference caused by debris. Cen-
trifugation causes a variable loss of erythrocytes 
and leukocytes, which does not allow a correct 
quantification. Relative losses due to centrifuga-
tion of red and white blood cells vary between 20 
and 80% (10).
Mostly, microscopy is used for a rough estimate of 
the amount of figurated elements. After centrifu-
gation, the specimen analysis can be performed 
using glass slides or a counting chamber. An ad-
vantage of using a counting chamber is a larger 
urine volume that can be examined, allowing a 
more precise analysis. However, differentiation ap-
pears to be easier through a thin liquid film, ob-
tained by a glass slide. Moreover, urine sediment 
analysis using counting chambers is time-consum-
ing. Simple particle differentiation without stain-
ing or phase contrast is not enough for renal ele-
ments. Much higher labor cost are associated with 
the advantage of a more precise result. A concen-
trated sample using a glass slide is proposed if 
manual evaluation is requested. Only when care-
fully working under standardized conditions, the 
results can be related to the original (in vivo) con-
centration (10).
Standardization of urine sediment examination 
consisting of urine volume, speed and time of cen-
trifugation, concentration of urine or sediment 
volume, volume of sediment examined and result 
reporting are essential to ensure accuracy and pre-
cision of urine microscopic examination. Unless 
urine samples are investigated within 4 hours from 
micturition (at 4 °C) or within 30 min at 20 °C, pre-
servatives should be added. Although 12 mL is the 
recommended urine volume for adult patients, a 
range of 5-12 mL urine is acceptable to examine 
the formed elements in urine. The acceptance of 
smaller urine specimens and the test protocol is 
determined by the individual laboratory. A nota-
tion on the lab report should be provided to men-
tion each deviation of the standard. A 5-minute 
centrifugation time at 400 g [RCF, relative centrifu-
gal force (g) = 1.118 x 10-5 x radius (cm) x RPM (revo-
lutions per minute)] preferably at 4 °C is necessary 
for optimal sediment concentration. The use of the 
centrifuge brake is contraindicated because of 
sample resuspension with decreased numbers of 
urinary formed elements. The classical manual 12:1 
sediment concentration step is followed by decan-
tation of the supernatant until 1 mL urine is left, 
which is gently resuspended. The volume of urine 
sediment examined is determined by standard-
ized molded plastic commercial slides and micro-
scopic optical properties. Bright-field microscopy, 
phase-contrast microscopy or polarized light mi-
croscopy are used with low- and high-power mag-
nification. The result reporting of a standardized 
microscope slide system should be supported by 
written operating procedures, characterized by a 
universal format, terminology (some components 
are expressed as qualitative terms and descriptions 
for fields of view, other components are enumer-
ated), predefined reference intervals and magnifi-
cation used for assessment. Finally, traceability of 
measured quantities and participation in an exter-
nal quality assessment program are also important 
(10,51).
Automated methods
Combining sediment microscopy and selective 
test strip examination of urine helps to assure ad-
equate specificity and sensitivity of urinalysis 
(4,45,50). Image analysis of native urine specimens 
was a first technological breakthrough, which al-
lowed analysis of much larger number of particles, 
resulting in improved results. However, a lot of ex-
pertise was required to identify the different im-
ages and substantial staff time was still needed 
(45,50,52).
Implementation of flow cytometry in the routine 
urinalysis meant a huge progress in basic urinaly-
sis. In a short time period, using only a small 
amount of native uncentrifugated urine, a huge 
amount of erythrocytes, leukocytes and epithelial 
cells can be evaluated (4). There appears to be a 
variable loss of these figurated elements in manu-
al methods due to the many intermediate steps in-
volved (centrifugation, decantation and resuspen-
sion of the specimen). Moreover, automation al-
lows a better standardization of particle analysis 
Biochemia Medica 2014;24(1):89–104  http://dx.doi.org/10.11613/BM.2014.011 
98
Delanghe J, Speeckaert M. Preanalytical requirements of urinalysis
(4,49). In contrast to manual methods, flow cyto-
metric analysis of casts has an acceptable coeffi-
cient of variation of 17% (19).
Manual microscopy and flowcytometry show a 
good agreement, except for casts and ‘yeast-like’ 
cells, where flow cytometry is inferior. Comparing 
within run CV’s for particle analysis between man-
ual methods, automated microscopy (Iris iQ200, 
Iris Diagnostics Inc, Chatsworth, Los Angeles, CA, 
USA) and flow cytometry (Sysmex UF-100, Sysmex 
Corporation, Kobe, Japan) showed that flow cy-
tometry had the best within run CV for erythro-
cytes, whereas the best within run CV for white 
blood cells was obtained by automated microsco-
py (53). In comparison with manual microscopy, 
the reproducibility of automated urine sediment 
analyzers (LabUMat-UriSed, 77 Elektronika Kft., 
Hungary and H800-FUS10s100, Dirui Industrial Co. 
Ltd., China) was better (8.5-33.3% vs. 4.1-28.5% and 
4.7-21.2%, respectively) (54). When counting equal 
ranges of particles, microscopy is generally inferior 
to automated methods (50,53).
Analysis of acute kidney injury proteins
Neutrophil gelatinase associated lipocalin (NGAL) 
is an emerging biomarker in the diagnosis of acute 
kidney injury. However, urinary tract infection and 
urinary neutrophil counts affect urinary values of 
this protein. Urinary leukocyte count correlates 
with NGAL concentrations: log(Y) (NGAL, μg/L) = 
1.284 + 0.439 log(X) (urinary white blood cells, 109 
cells/L); r = 0.518. In parallel, a correlation between 
NGAL and the bacterial count has been reported. 
In leukocyturia or tubular damage (e.g. intensive 
care patients), a mathematical correction has been 
suggested in cases with pyuria (> 100 × 109 cells/L) 
and urinary NGAL concentration > 100 μg/L (55).
Importance of the preanalytical phase in 
urine toxicology
As most drugs are characterized by a predomi-
nantly renal excretion, urine is the preferred speci-
men for inexpensive, noninvasive and quick sub-
stance abuse tests (56). The Clinical and Laboratory 
Standards Institute (CLSI) developed guidelines 
concerning specific requirements for the technical 
performance of urinary drug testing (57). The Eu-
ropean Workplace Drug Testing Society (58), the 
Substance Abuse and Mental Health Services (59), 
the Swiss Working Group for Drugs of Abuse Test-
ing Guidelines (60), the Joint Technical Committee 
(61) and the United Kingdom (62) proposed some 
criteria for urine validity testing based on several 
parameters: urinary creatinine concentration, spe-
cific gravity, nitrite, pH and presence of exogenous 
or endogenous substances. After checking of the 
integrity of the sample, positive screening tests are 
followed by confirmation methods (63).
It should be stressed that an appropriate collec-
tion, handling and testing of urine samples are 
necessary to avoid false-positive, false-negative 
and inconclusive test results (56). Several specimen 
tampering methods have been used to avoid de-
tection: substitution of urine by another fluid, 
adulteration by addition of a foreign material, dilu-
tion of the urine sample by adding water. The fol-
lowing countermeasures have been proposed to 
prevent deceptive switching or purposeful con-
tamination: (a) placing bluing agent (dye) in the 
toilet bowl; (b) requesting “photo” identification of 
the subject; (c) leaving coats, briefcases or purses 
outside of the collection area; (d) washing and dry-
ing hands before providing a sample; (e) observa-
tion of collection; and (f) taking temperature of the 
urine within four minutes of collection (57).
False-positive results can also be caused by opera-
tor errors, cleaning the skin with isopropyl alcohol, 
contamination of equipment, specimen confusion, 
mislabeling and misidentification of the subject, 
breaks in the chain of custody and errors during 
the measurement process (57). To decrease the in-
cidence of preanalytical problems, several precau-
tions should be taken into account. An identifica-
tion and laboratory data system should be imple-
mented; the condition of seals, shipping cartons, 
specimen containers and urine specimens should 
be checked for integrity; the information on the 
specimen requisition form and the external chain-
of-custody form should be reviewed for complete-
ness and accuracy (57).
Urine toxicology specimens should be stored at a 
temperature of 2-8 °C for five days, minimizing de-
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terioration and protecting samples from tamper-
ing. Storage at ≤ -5 °C is recommended if analysis 
is postponed for more than five working days. Be-
sides the analysis of medical samples, some addi-
tional requirements are prescribed for forensic 
specimens: (a) storage of the sample in the original 
container, (b) minimization of the number of 
freeze/thaw cycles to reduce specimen degrada-
tion, (c) use of control measures to ensure speci-
men integrity and (d) recordkeeping using internal 
and external chain-of-custody systems (57).
Finally, over-the-counter (OTC) drugs, prescribed 
medications and some foodstuff, which are chemi-
cally related to drugs of abuse, can also be detect-
ed by urinary drug tests (56). Amphetamine-relat-
ed OTC drugs (ephedrine, pseudoephedrine and 
phenylpropanolamine) are known for their cross-
reacting capacities with amphetamines screening 
immunoassays (64). False-positive opiate drug 
tests have been reported after poppy food inges-
tion (65). To reduce cross-reactivity and to increase 
drug specificity, many drug tests are routinely 
modified (56).
Preanalytical aspects of urine 
metabolomics
The monitoring of the impact of the preanalytical 
steps on urine sample quality and stability can be 
fulfilled by 1H NMR metabolic profiling. Standard 
operating procedures (SOPs) for deposition in 
biobanks have been proposed (66). Stability of the 
urine metabolic profile at various storage temper-
atures was studied for different preanalytical treat-
ments (prestorage centrifugation, filtration and 
addition of sodium azide). According to the Euro-
pean Consensus Expert Group Report (67), 
biobanking procedures for urine should consider 
the following recommendations: (i) cells and par-
ticulate matter should be removed; (ii) storage of 
specimens at a temperature of -80 °C or lower; (iii) 
time limits for processing should be experimental-
ly defined; (iv) specimens should be stored with-
out additives, unless specified for a particular 
downstream analysis.
Is there an influence of centrifugation on 
analysis results?
To avoid the presence of components affecting 
the spectral quality, standard protocols (68) for 
NMR analysis of urine samples require a centrifu-
gation at 14,000 Relative Centrifugal Force (RCF) (5 
min, 4 °C). A high speed may cause destruction of 
cells and a release of cellular components, affect-
ing the NMR profile. The most distant from non-
precentrifuged samples are the samples precentri-
fuged at a speed in the 1,000-3,000 RCF range, 
while samples precentrifuged at 11,000 RCF are 
slightly closer to the aliquots that do not undergo 
any precentrifugation. If a mild precentrifugation 
(1,000-3,000 RCF) is applied, cellular components 
are spun down. The subsequent 14,000 RCF cen-
trifugation of the supernatant is useful for elimina-
tion of suspended particles. Precentrifuged or 
non-precentrifuged samples show differences in 
metabolic profile, which are attributable to chemi-
cal shift changes. Soluble components released by 
cells in fresh urine may alter the physiochemical 
properties of the solution. Presence of cellular 
components affects NMR profiles even if non-fresh 
samples are analysed. NMR metabolic profiles of 
samples that have undergone a mild (RCF between 
600 and 2,500) precentrifugation before freezing 
at -80 °C differ from non-precentrifuged samples 
stored for 7 days at the same temperature. This ef-
fect is less pronounced after storage in liquid ni-
trogen.
Which is the preferable preservation method?
The two most commonly used preservation meth-
ods have been compared: addition of sodium 
azide and the use of filtration (69) with or without 
a precentrifugation step. Spectral variations were 
followed after urine processing or thawing. pH-
sensitive metabolites undergoing chemical shift 
variations show changes over time. Sample alka-
linisation is consistent with shift variations for the 
He1 N-methylhistidine; also, changes in the chemi-
cal shifts of the resonances of xantine are observed 
with time. For some molecules, concentration 
changes are observed: whereas an increase of suc-
cinate and acetate are reported with time, gluta-
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mate/glutamine, urea and lactate concentrations 
decrease. Filtration stabilizes NMR spectra over 
time.
What are the recommendations?
The origin of changes that affect the NMR spectra 
can be the result of a combination of chemical re-
actions, bacterial growth and enzymatic activities 
of urine. For maintaining the original urine metab-
olome, the following procedures for optimal 
processing and management have been proposed: 
(i) the combined use of a mild pre-centrifugation 
(RCF between 1,000 and 3,000 at 4 °C) and filtra-
tion should remove cells and particulate matters; 
(ii) samples should be stored long-term in liquid 
nitrogen to avoid destruction of residual cells; (iii) 
fast processing; (iv) storage at 4°C between collec-
tion and processing. Addition of additives is to be 
avoided since the required concentrations will 
generate NMR signals covering the resonance of 
metabolites and may affect the original NMR pro-
files. For the maintenance of the metabolome, 
time between collection and processing and the 
temperature at which urine specimens are kept 
during this time delay should be reduced (68).
Optimal urine quality management in a 
routine clinical laboratory
To improve the optimal urine quality management 
in routine clinical laboratories, the CLSI develops 
best practices in clinical and laboratory testing by 
using a core set of “quality system essentials” and 
promotes the use of these standards worldwide 
(13). Besides, the International Standards Organiza-
tion (ISO) document 15189:2007 lists particular re-
quirements for quality and competence (70). Look-
ing at the most recent CLSI recommendations, it is 
stated that high quality urine samples can only be 
delivered by appropriate urine collection tubes 
(made of clear plastic and with conical bases for 
microscopic analysis of urine sediment) and leak-
proof containers. In addition, high quality pipettes 
and standardized microscope slides with calibrat-
ed volumes for analysis of urine sediment are es-
sential. A second important preanalytical point is 
whether preservatives are used or not, as unpre-
served samples can give rise to bacterial prolifera-
tion. Refrigeration for storage or transportation 
should always be followed by equilibration to 
room temperature and well mixing before analy-
sis. Several drugs can disturb the test results of uri-
nalysis, which implies that a ‘drug-free” specimen 
can only be achieved by temporary cessation of a 
particular medication. Besides the influence of 
clarity and colour of the urine samples, a number 
of substances can interfere with dipstick tests, ac-
cording to the type of test strip. In comparison 
with random urine testing, the examination of 
chemical analytes is more reliable when timed 
sampling is used, which is however prone to pre-
analytical errors. Microbiological cultures and anti-
biotic susceptibility testing can be influenced by 
contamination, defined as the presence of more 
than 10,000 CFU/mL of two or more organisms. 
Random urine samples have a higher contamina-
tion risk in comparison with midstream clean catch 
samples. False-positive results can also be caused 
by bacterial overgrowth due to delays in the trans-
port of samples. Treatment with antibiotics prior 
to urine sampling can lead to false-negative re-
ports.
Summary
Urinalysis plays a key role as an aid in the differen-
tial diagnosis of many renal and urologic diseases. 
The preanalytical phase, including biological col-
lection, identification, storage and specimen trans-
port, preparation for analyses of the specimen (e.g. 
centrifugation, freezing, thawing, aliquoting and 
sampling) largely determines the analytical proc-
ess and the over-all quality. For that reason we 
have presented guidelines for a correct preanalyti-
cal management of urine samples in a flowchart 
(Figure 1).
As urine samples are often collected by patients 
themselves, the analysis of urine is one of the most 
susceptible examinations to preanalytical issues. 
In addition to the insurance of correct sampling, 
the clinical lab should optimize transport and sam-
ple preservation. Next to the use of a primary urine 
container, it is recommended to split the original 
urine sample into various smaller aliquots for mor-
phological, microbiological and chemical analyses, 
decreasing the risk of contamination. Implementa-
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Patient preparation
Education of patients, general practioners and laboratory staff -
Explaining effect of dietary intake, diuresis, exercise and other interferents -
Illustrated sampling instructions -
Washing glans penis of men and introitus of women -
Use of soap or antiseptics is not recommended -
Collection of specimens, preservation, transport and storage
Routine urine samples for chemical, bacterial or particle analysis1 . 
Clean-catch or midstream urine of 1st morning urine (most analyses) or 2nd morning urine (morphology) -
A sterile urine collection is mandatory for bacteriological culture -
Urine collection container design: easy sampling, optimal transport, sensitive detection of pathogens, being free of inter- -
fering agents and made of non-absorbing materials, with no influence on any analyte
Collection volume: 5-12 mL or 24-h urine collection -
Division of original primary sample into smaller aliquots for morphological, microbiological and -  chemical analyses to de-
crease risk of contamination
Unless urine samples are investigated within 4 h from micturition (at 4 °C) or within 30 min at 20 °C, preservatives (lyophi- -
lised formulations) should be added
Check regularly current requirements from reference laboratories. -
5-min centrifugation time at 400 x g -
Classical manual 12:1 sediment concentration step -
Use bright-field microscopy, phase-contrast microscopy or polarized light microscopy with low- and high-power magnifica- -
tion
Be aware of the interfering effects of different urine components on test strip analyses -
Result reporting: written operating procedures, universal format, terminology, predefined reference intervals and magni- -
fication used for assessment, traceability of measured quantities and participation in an external quality assessment pro-
gram
Urine toxicology2 . 
Urine validity testing based on creatinine concentration, specific gravity, nitrite, pH and presence of exogenous or endog- -
enous substances
Storage at 2-8 °C for 5 days, storage at ≤ -5 °C if analysis is postponed for > 5 days -
Urine metabolomics3 . 
Combined use of a mild pre-centrifugation (RCF between 1,000 and 3,000 at 4 °C) and filtration -
Long-term storage in liquid nitrogen at a temperature of ≤ -80 °C; storage without additives, unless specified for a particu- -
lar downstream analysis
Fast processing -
Storage at 4 °C between collection and processing -
Forensic specimens4 . 
Storage of the sample in the original container -
Minimization of the number of freeze/thaw cycles to reduce specimen degradation -
Use of control measures to ensure specimen integrity -
Recordkeeping using internal and external chain-of-custody systems -
Sample procedures
1 . Erythrocytes, leukocytes: strip examination (level 1), standardized urine sediment (level 2) or advanced chamber counting 
(level 3)
2 . Albumin and other proteins: strip examination (level 1), quantitative field measurement (level 2) or accurate measurement 
traced to the CRM 470 standard (level 3)
3 . Bacteria: dipslide culture (level 1), culture with a 1 µL disposable loop for 24-48 h (level 2) or quantitative titration of 10-100 µL 
inocula on 2 different (CLED and haematin) agar plates (level 3)
4 . Urine volume rate (diuresis): strip examination (level 1), creatinine and refractometry (level 2) or quantitative measurement of 
osmolality (level 3) 
Figure 1. Flowchart illustrating the guidelines for a correct preanalytical management of urine samples.
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tion of vacuum systems has enabled swift trans-
port of urine specimens and limits the risk of con-
tamination and errors. The disruptive force gener-
ated by the vacuum on brittle figurated elements 
(e.g. casts) is generally underestimated and insuffi-
ciently examined.
As modern urinalysis (flow cytometry, automated 
microscopy) is characterized by a low CV, preana-
lytical aspects of urinalysis are of growing impor-
tance. Special attention should be paid to casts, 
the most brittle structures in sediment analysis. 
There is a call for novel studies to optimize the 
analysis of urine sediment. The investigation of 
dysmorphic erythrocytes, in particular acan-
thocytes, is also important in the diagnosis of 
glomerular disorders. The analysis of urine sedi-
ment cannot yet be abandoned in the 21st centu-
ry.
The time lag between voiding and examination of 
urine is a limiting factor for the over-all diagnostic 
accuracy. No preservatives are needed for many 
chemical analytes examined with test strips, if the 
sample is refrigerated and the analysis can be per-
formed within 24 hours. If a delay cannot be avoid-
ed and refrigeration is not possible, urine contain-
ers prefilled with preservative (boric acid alone or 
in combination with formate or other stabilizers) 
may be used. Since in everyday routine, most of 
the clinical laboratories are receiving urine sam-
ples with delays of several hours, we recommend 
to use refrigeration as a preservative instead of 
chemical preservatives for urinalysis according to 
the guidelines of the NCCLS (13). If commercially 
available preservatives are used, their influence on 
chemical properties and appearance of particles 
should be kept in mind. Ideally, preservatives are 
present in a lyophilized form. An important inter-
ference of preservatives with several chemical as-
says has been demonstrated. Most urine preserva-
tives were originally only intended for preventing 
bacterial growth and not to perform chemical 
analysis or particle counting. The combined use of 
test strip analysis and particle analysis (manual or 
automated) as a first step before bacteriological 
analysis has been proposed by guidelines in differ-
ent algorithms to assure efficient use of resources 
(4). As there is currently no preservative that is able 
to stabilize urine for chemical and particle analysis, 
novel research projects are needed. Until the de-
velopment of such a preservative, clinical labs 
need to prepare two aliquots. Only a preservative 
stabilizing both bacteria and urinary particles can 
be considered as a valid alternative for sample re-
frigeration. As urine metabolomics has become a 
hot topic, the European Consensus Expert Group 
Report has published a number of recommenda-
tions for biobanking procedures (67).
Potential conflict of interest
None declared.
References
 1. Coppens A, Speeckaert M, Delanghe J. The pre-anal-
ytical challenges of routine urinalysis. Acta Clin Belg 
2010;65:182-9.
 2. Carlson DA, Statland BE. Automated urinalysis. Clin Lab 
Med 1988;8:449-61.
 3. Fogazzi GB, Cameron JS, Ritz E, Ponticelli C. The history of 
urinary microscopy to the end of the 19th century. Am J Nep-
hrol 1994;14:452-7. http://dx.doi.org/10.1159/000168764.
 4. Langlois MR, Delanghe JR, Steyaert RS, Everaert KC, De 
Buyzere ML. Automated flow cytometry compared with 
an automated dipstick reader for urinalysis. Clin Chem 
1999;45:118-22.
 5. Caleffi A, Manoni F, Alessio MG, Ottomano C, Lippi G. Qu-
ality in extra-analytical phases of urinanalysis. Bioche-
mia Medica 2010;20:179-83. http://dx.doi.org/10.11613/
BM.2010.022.
 6. Howanitz PJ, Howanitz JH. Quality control for the clinical 
laboratory. Clin Lab Med 1983;3:541-51.
 7. Lippi G, Becan-McBride K, Behúlová D, Bowen RA, Church S, 
Delanghe J, et al. Preanalytical quality improvement: in qu-
ality we trust. Clin Chem Lab Med 2013;51:229-41. http://
dx.doi.org/10.1515/cclm-2012-0597.
 8. Stankovic AK, DiLauri E. Quality improvements in the pre-
analytical phase: focus on urine specimen workflow. Clin 
Lab Med 2008;28:339-50. http://dx.doi.org/10.1016/j.
cll.2007.12.011.
http://dx.doi.org/10.11613/BM.2014.011 Biochemia Medica 2014;24(1):89–104 
  103
Delanghe J, Speeckaert M. Preanalytical requirements of urinalysis
 9. Delanghe JR. New screening diagnostic techniques in uri-
nalysis. Acta Clin Belg 2007;62:155-61.
10. European Confederation of Laboratory Medicine. European 
urinalysis guidelines. Scand J Clin Lab Investig 2000;60:1-
96.
11. Miler M, Šimundić AM. Low level of adherence to instruc-
tions for 24-hour urine collection among hospital out-
patients. Biochem Med 2013;23:316-20. http://dx.doi.
org/10.11613/BM.2013.038.
12. Cotten SW, Duncan DL, Burch EA, Seashore CJ, Hammett-
Stabler CA. Unexpected interference of baby wash pro-
ducts with a cannabinoid (THC) immunoassay. Clin Bio-
chem 2012;45:605-9. http://dx.doi.org/10.1016/j.clinbio-
chem. 2012.02.029.
13. Clinical and Laboratory Standards Institute. Urinalysis and 
Collection, Transportation, and Preservation of Urine Spe-
cimens; Approved Guideline-Third Edition. NCCLS docu-
ment GP16-A3. Available at: http://www.clsi.org/. Assessed 
November 11th 2013.
14. Norden CW, Kass EH. Bacteriuria of pregnancy - a criti-
cal appraisal. Ann Rev Med 1968;19:431-70. http://dx.doi.
org/10.1146/annurev.me.19.020168.002243.
15. Roberts AP, Robinson IE, Beard RW. Some factors affec-
ting bacterial colony counts in urinary infection. Br Med J 
1967;I:400-3. http://dx.doi.org/10.1136/bmj.1.5537.400.
16. Dinda AK, Saxena S, Guleria S, Tiwari SC, Dash SC, Sriva-
stava RN, et al. Diagnosis of glomerular haematuria: role 
of dysmorphic red cell, G1 cell and bright-field microsco-
py. Scand J Clin Lab Invest 1997;57:203-8. http://dx.doi.
org/10.3109/00365519709060028.
17. Manoni F, Gessoni G, Alessio, MG, Caleffi A, Saccani G, Sil-
vestri MG, et al. Mid-stream vs. first-voided urine collecti-
on by using automated analyzers for particle examinati-
on in healthy subjects: an Italian multicenter study. Clin 
Chem Lab Med 2012;50:679-84. http://dx.doi.org/10.1515/
cclm.2011.823.
18. Kouri TT, Gant VA, Fogazzi GB, Hofmann W, Hallander HO, 
Guder WG. Towards European urinalysis guidelines. Intro-
duction of a project under European Confederation of La-
boratory Medicine. Clin Chim Acta 2000;297:305-11. http://
dx.doi.org/10.1016/S0009-8981(00)00256-4.
19. Delanghe J, Langlois M. Pre-analytical effects of vacuum 
aspiration on urinalysis. Proceedings of the 5th Symposi-
um: preanalytical phase in patient care and hospital ma-
nagement. Pratolino 1999.
20. Hara F, Shiba K. Nonspecific binding of urinary albumin on 
preservation tube. Jpn J Clin Chem 2003;32:28-9.
21. Miller WG, Bruns DE, Hortin GL, Sandberg S, Aakre KM, 
McQueen MJ, et al. Current issues in measurement and re-
porting of urinary albumin excretion. Clin Chem 2009;55:24-
38. http://dx.doi.org/10.1373/clinchem.2008.106567.
22. Fogazzi GB, Verdesca S, Garigali G. Urinalysis: core curricu-
lum 2008. Am J Kidney Dis 2008;51:1052-67. http://dx.doi.
org/10.1053/j.ajkd.2007.11.039.
23. Eisinger SW, Schwartz M, Dam L, Riedel S. Evaluation of the 
BD Vacutainer Plus Urine C&S Preservative Tubes Compared 
With Nonpreservative Urine Samples Stored at 4{degrees}C 
and Room Temperature. Am J Clin Pathol 2013;140:306-13. 
http://dx.doi.org/10.1309/AJCP5ON9JHXVNQOD.
24. Nickander KK, Shanholtzer CJ, Peterson LR. Urine culture 
transport tubes: effect of sample volume on bacterial toxi-
city of the preservative. J Clin Microbiol 1982;15:593-5.
25. Kouri TT, Vuotari L, Pohjavaara S, Laippala P. Preservation 
of urine for flow cytometric and visual microscopic testing. 
Clin Chem 2002;48:900-5.
26. Gillespie T, Fewster J, Masterton RG. The effect of specimen 
processing delay on borate urine preservation. J Clin Pathol 
1999;52:95-8. http://dx.doi.org/10.1136/jcp.52.2.95.
27. Guy M, Borzomato JK, Newall RG, Kalra PA, Price CP. Protein 
and albumin-to creatinine ratios in random urines accura-
tely predict 24 h protein and albumin loss in patients with 
kidney disease. Ann Clin Biochem 2009;46:468-76. http://
dx.doi.org/10.1258/acb.2009.009001.
28. Kouri T, Malminiemi O, Penders J, Pelkonen V, Vuota-
ri L, Delanghe J. Limits of preservation of samples for uri-
ne strip tests and particle counting. Clin Chem Lab Med 
2008;46:703-13. http://dx.doi.org/10.1515/CCLM.2008.122.
29. Porter IA, Brodie J. Boric acid preservation of urine sam-
ples. Brit Med J 1969;2:353-5. http://dx.doi.org/10.1136/
bmj.2.5653.353.
30. Chanoine JP, Bourdoux P, Vo Thi NB, Ermans AM. Iodine 
contamination of urine samples by test strips. Clin Chem 
1987;33:1935.
31. Van Acker JT, Verstraete AG, Van Hamme MA, Delanghe J. 
Falsely increased urinary caffeine attributable to contami-
nation by urine test strips. Clin Chem 1999;45:1315-7.
32. Burtis CA, Ashwood ER, eds. Textbook of Clinical Chemistry. 
2nd ed. Philadelphia: WB Saunders, 1994.
33. Henry JB. Clinical Diagnosis and Management by Labora-
tory Methods, 19th ed. Philadelphia: WB Saunders, 1996.
34. Mundt L, Shanahan K, eds. Graff’s Textbook of Urinalysis 
and Body Fluids. 2nd ed. Philadelphia: Wolters Kluwer, 
2010.
35. Brandt R, Guyer KE, Banks WL Jr. Urinary glucose and vita-
min C. Am J Clin Pathol 1977;68:592-4.
36. Court JM, Davies HE, Ferguson R. Diastix and ketodiastix: a 
new semiquantitative test for glucose in urine. Med J Aust 
1972;1:525-8.
37. Smith BC, Peake MJ, Fraser CG. Urinalysis by use of mul-
ti-test reagent strips: two dipsticks compared. Clin Chem 
1977;23:2337-40.
38. Wilson DM. Urinalysis and other tests of renal function. 
Minn Med 1975;58:9-17.
39. Rasoulpour M, McLean RH, Raye J, Shah BL. Pseudohema-
turia in neonates. J Pediatr 1978;92:852-3. http://dx.doi.
org/10.1016/S0022-3476(78)80179-6.
40. Patel HP. The abnormal urinalysis. Pediatr Clin N Am 
2006;53:325-37. http://dx.doi.org/10.1016/j.pcl.2006. 02.004.
41. Beer JH, Vogt A, Neftel K, Cottagnoud P. False positive re-
sults for leucocytes in urine dipstick test with common 
antibiotics. BMJ 1996;313:25. http://dx.doi.org/10.1136/
bmj.313.7048.25.
42. Kierkegaard H, Feldt-Rasmussen U, Hørder M, Andersen HJ, 
Jørgensen PJ. Falsely negative urinary leukocyte counts due 
to delayed examination. Scand J Clin Lab Invest 1980;40:259-
61. http://dx.doi.org/10.3109/00365518009095576.
Biochemia Medica 2014;24(1):89–104  http://dx.doi.org/10.11613/BM.2014.011 
104
Delanghe J, Speeckaert M. Preanalytical requirements of urinalysis
43. Mobley HL, Warren JW. Urease-positive bacteriuria and 
obstruction of long-term urinary catheters. J Clin Microbi-
ol 1987;25:2216-7.
44. Griffith DP, Musher DM, Itin C. Urease. The primary ca-
use of infection- induced urinary stones. Investig Urol 
1976;13:346-50.
45. Fassett RG, Horgan BA, Mathew TH. Detection of glo-
merular bleeding by phase-contrast microscopy. Lan-
cet 1982;i:1432-4. http://dx.doi.org/10.1016/S0140-6736-
(82)92451-5.
46. Kitamoto Y, Tomita M, Akamine M, Inoue T, Itoh J, Taka-
mori H, et al. Differentiation of hematuria using a uniqu-
ely shaped red cell. Nephron 1993;64:32-6. http://dx.doi.
org/10.1159/000187274.
47. Guder WG, Ivandic M, Hofmann W. Physiopathology of 
proteinuria and laboratory diagnostic strategy based on 
single protein analysis. Clin Chem Lab Med 1998;36:935-9. 
http://dx.doi.org/10.1515/CCLM.1998.162.
48. Hanneman-Pohl K, Kampf SC. Automation of Urine Sedi-
ment Examination: a comparison of the Sysmex UF-100 
Automated Flow Cytometer with Routine Manual Dia-
gnosis. Clin Chem Lab Med 1999;37:753-64. http://dx.doi.
org/10.1515/CCLM.1999.116.
49. Ben-Ezra J, Bork L, McPherson RA. Evaluation of the Sy-
smex UF-100 automated urinalysis analyzer. Clin Chem 
1998;44:92-5.
50. Mayo S, Acevedo D, Quiñones-Torrelo C, Canós I, Sancho 
M. Clinical laboratory automated urinalysis: comparison 
among automated microscopy, flow cytometry, two test 
strips analyzers, and manual microscopic examination of 
the urine sediments. J Clin Lab Anal 2008;22:262-70. http://
dx.doi.org/10.1002/jcla.20257.
51. Brunzel NA, ed. Fundamentals of Urine and Body Fluid 
Analysis. 3rd ed. St. Louis, MO: Elsevier, Saunders, 2013.
52. Linko S, Kouri TT, Toivonen E, Ranta PH, Chapoulaud E, Lalla 
M. Analytical performance of the Iris iQ200 automated uri-
ne microscopy analyzer. Clin Chim Acta 2006;372:54-64. 
http://dx.doi.org/10.1016/j.cca.2006.03.015.
53. Chien TI, Kao JT, Liu HL, Lin PC, Hong JS, Hsieh HP, et al. 
Urine sediment examination: A comparison of auto-
mated urinalysis systems and manual microscopy. Clin 
Chim Acta 2007;384:28-34. http://dx.doi.org/10.1016/j.
cca.2007.05.012.
54. Yüksel H, Kiliç E, Ekinci A, Evliyaoğlu O. Comparison of fu-
lly automated urine sediment analyzers H800-FUS100 and 
labumat-urised with manual microscopy. J Clin Lab Anal 
2013;27:312-6. http://dx.doi.org/10.1002/jcla.21604.
55. Decavele AS, Dhondt L, De Buyzere ML, Delanghe JR. In-
creased urinary neutrophil gelatinase associated lipoca-
lin in urinary tract infections and leukocyturia. Clin Chem 
Lab Med 2011 49:999-1003. http://dx.doi.org/10.1515/
CCLM.2011.156.
56. Kandall SR, ed. Improving Treatment for Drug-Exposed 
Infants Treatment Improvement Protocol (TIP) Series 5. 
1993. Available at: http://www.ncbi.nlm.nih.gov/books/
NBK64750/. Assessed November 10th 2013.
57. Clinical and Laboratory Standards Institute. Urine drug te-
sting in the clinical laboratory; Approved guideline. NCCLS/
CLSI T/DM8-A. 1999. Available at: http://www.clsi.org/. 
Assessed November 11th 2013.
58. European Workplace Drug Testing Society (EWDTS). Eu-
ropean Laboratory Guidelines for Legally Defensible Wor-
kplace Drug Testing, 2003. Available at: http://www.ewdts.
org/. Assessed November 10th 2013.
59. Department of Health and Human Services – Substance 
Abuse and Mental Health Services Administration. Propo-
sed revisions to mandatory guidelines for federal workpla-
ce drug testing programs, 2004. Federal Register p. 19673-
19732. Available at: http://www.gpo.gov/fdsys/pkg/FR-2004
-04-13/pdf/04-7984.pdf/. Assessed November 10th 2013.
60. Swiss Working Group for Drugs of Abuse Testing Guideli-
nes (AGSA) Drugs of Abuse Testing Guidelines, 2003. Ava-
ilable at: http://faculty.ksu.edu.sa/18856/454/AGSA%20
%20Drugs%20of%20Abuse%20Testing%20Guidelines.pdf. 
Assessed November 10th 2013.
61. Joint Technical Committee CH-036 Analysis of Body Fluids 
and Wastes. Australian/New Zealand Standard TM: Proce-
dures for the collection, detection and quantitation of dru-
gs of abuse in urine, 2001. Available at: http://www.sai-
global.com/pdftemp/previews/osh/as/as4000/4300/4308.
pdf/. Assessed November 11th 2013.
62. Steering Group UK. United Kingdom laboratory guidelines 
for legally defensible workplace drug testing: urine drug te-
sting. 2001;1-38.
63. Penders J, Verstraete A. Laboratory guidelines and standards 
in clinical and forensic toxicology. Accred Qual Assur 2006; 
11:284-90. http://dx.doi.org/10.1007/s00769-006-0131-y.
64. Stout PR, Klette KL, Horn CK. Evaluation of ephedrine, pse-
udoephedrine and phenylpropanolamine concentrations 
in human urine samples and a comparison of the specifi-
city of DRI amphetamines and Abuscreen online (KIMS) 
amphetamines screening immunoassays. J Forensic Sci 
2004;49:160-4. http://dx.doi.org/10.1520/JFS2003233.
65. Lachenmeier DW, Sproll C, Musshoff F. Poppy seed fo-
ods and opiate drug testing--where are we today? Ther 
Drug Monit 2010;32:11-8. http://dx.doi.org/10.1097/
FTD.0b013e3181c0eee0.
66. Bernini P, Bertini I, Luchinat C, Nincheri P, Staderini S, Tu-
rano P. Standard operating procedures for pre-analytical 
handling of blood and urine for metabolomic studies and 
biobanks. J Biomol NMR 2011;49:231-43. http://dx.doi.
org/10.1007/s10858-011-9489-1.
67. Yuille M, Illig T, Hveem K, Schmitz G, Hansen J, Neumaier M, 
et al. Laboratory management of samples in biobanks: Eu-
ropean consensus expert group report. Biopreserv Biobank 
2010;8:65-9. http://dx.doi.org/10.1089/bio.2010.8102.
68. Beckonert O, Keun HC, Ebbels TM, Bundy J, Holmes E, Lin-
don JC, et al. Metabolic profiling, metabolomic and meta-
bonomic procedures for NMR spectroscopy of urine, pla-
sma, serum and tissue extracts. Nat Protoc 2007;2:2692-
703. http://dx.doi.org/10.1038/nprot.2007.376.
69. Saude EJ, Sykes BD. Urine stability for metabolomic stu-
dies: effects of preparation and storage. Metabolomi-
cs 2007;3:19-27. http://dx.doi.org/10.1007/s11306-006-
0042-2.
70. Medical laboratories — Particular requirements for quali-
ty and competence. ISO document 15189, International Or-
ganization for Standardization, Geneva, 2007. Available 
at: http://www.iso-15189.com/. Assessed November 11th 
2013.
